Owl Creek Asset Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Owl Creek Asset Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-722,439	Closed	-$217K	–	78
2023 Q4	$217K	Sell	722,439 -27,361	-4%	-$8.45K	0.02%	33
2023 Q3	$262K	Sell	749,800 -200	-0%	-$53	0.01%	39
2023 Q2	$120K	Hold	750,000	–	–	0.01%	88
2023 Q1	$109K	Hold	750,000	–	–	0.01%	117
2022 Q4	$45K	Hold	750,000	–	–	﹤0.01%	153
2022 Q3	$29K	Hold	750,000	–	–	﹤0.01%	211
2022 Q2	$83K	Hold	750,000	–	–	﹤0.01%	203
2022 Q1	$135K	Hold	750,000	–	–	0.01%	236
2021 Q4	$240K	Buy	+750,000	New	+$237K	0.02%	253

Owl Creek Asset Management's DMAQR Position: Q1 2024 in Review

Owl Creek Asset Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 722,439 shares — an estimated $217K sold.

Owl Creek Asset Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $262K in Q3 2023. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Owl Creek Asset Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Owl Creek Asset Management sold 722,439 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $217K.
Owl Creek Asset Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Owl Creek Asset Management's Deep Medicine Acquisition Corp. Rights position peaked at $262K in Q3 2023.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Owl Creek Asset Management's 13F filing for Q1 2024, filed 15 May 2024.